Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders: A Secondary Outcome Analysis of a Pragmatic, Randomized Trial (BeSt InTro)

BACKGROUND: Depressive symptoms are frequent in schizophrenia and associated with a poorer outcome. Currently, the optimal treatment for depressive symptoms in schizophrenia remains undetermined. Amisulpride, aripiprazole, and olanzapine all have antidepressive pharmacodynamic properties, ranging fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjelby, Eirik, Gjestad, Rolf, Fathian, Farivar, Sinkeviciute, Igne, Alisauskiene, Renata, Anda, Liss, Løberg, Else-Marie, Reitan, Solveig Klæbo, Joa, Inge, Larsen, Tor Ketil, Rettenbacher, Maria, Berle, Jan Øystein, Fasmer, Ole Bernt, Kroken, Rune Andreas, Johnsen, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155702/
https://www.ncbi.nlm.nih.gov/pubmed/37083542
http://dx.doi.org/10.1097/JCP.0000000000001679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155702/
https://www.ncbi.nlm.nih.gov/pubmed/37083542
http://dx.doi.org/10.1097/JCP.0000000000001679

Ejemplares similares